[Comparative study of the treatment of pulmonary tuberculosis with isoprodian and pyrazinamide as well as isoprodian and rifampicin].
D000328:Adult; D000368:Aged; D000995:Antitubercular Agents / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use*; D007539:Isonicotinic Acids / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011515:Prothionamide / Q000627:therapeutic use*; D011718:Pyrazinamide / Q000627:therapeutic use*; D011859:Radiography; D012293:Rifampin / Q000627:therapeutic use*; D013183:Sputum / Q000382:microbiology; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000000981:diagnostic imaging / Q000188:drug therapy*
D000995:Antitubercular Agents; D004338:Drug Combinations; D007539:Isonicotinic Acids; D011718:Pyrazinamide; C011004:isoprodian; D011515:Prothionamide; D003622:Dapsone; D007538:Isoniazid; D012293:Rifampin
Vergleichende Studie der Behandlung der Lungentuberkulose mit Isoprodian und Pyrazinamid bzw. Isoprodian und Rifampicin.